» CRYOcheck™ Factor IX Deficient Plasma

HEMOSTASIS COAGULATION ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS INTRINSIC PATHWAY FACTOR IX

CRYOcheck™ Factor IX Deficient Plasma

Fresh frozen plasmas

Plasma deficient for Factor IX assay.

CRYOcheck™Factor IX Deficient is a frozen, immuno-depleted, platelet poor plasma certified to have less than 1% FIX.

Access publications on the manufacturer's website

Reference	FDP09-10
Presentation	Kit
Format	25 x 1.0 mL
Number of assays	500
Quote

Reference	FDP09-15
Presentation	Kit
Format	25 x 1.5 mL
Number of assays	750
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
FDP09-10	Kit	25 x 1.0 mL	500
FDP09-15	Kit	25 x 1.5 mL	750

Price list, safety data sheets and notices are accessible to our registered customers.

CRYOcheck™ Factor IX Deficient Plasma Certificate of analysis

FIX is a vitamin K dependent glycoprotein synthesized by the liver. FIX can be activated to FIX in FIXa by FXIa or by FVIIa in the presence of phospholipids and calcium. A person who is deficient in FIX has hemophilia B.

CRYOcheck™Factor Deficient Plasma consist of pools of citrated human normal plasmas which have been depleted into a coagulation factor by immunoadsorption, buffered with HEPES buffer, aliquoted and frozen rapidly.

- Certificate of analysis supplied with each batch.
- Expiration date of 3 years from the date of manufacture with storage between -40 °C and -80 °C.
- The other factors have been tested and the results are provided on the Certificate of Analysis that accompanies each lot number.
- Contains no inhibitor, suitable for research of inhibitors (Bethesda or Nijmegen)

- CE adaptation on many analyzers on the market
- Technical validation file
- Reserved lots
- Ready to use

- 25 cryotubes x 1 mL or 1.5 mL of frozen plasma

CRYOcheck™ Abnormal 1 Reference Control
CRYOcheck™ Abnormal 2 Reference Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Reference Control Normal
Very Low IX Control Plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS INTRINSIC PATHWAY FACTOR IX